Experiment 449653
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | CASSIDY,J: GRAHAM,MA: HUININK,WTB: MC DANIEL,C: SETANOIANS,A: RANKIN,EM: KERR,DJ: KAYE,SB:. (1993). PHASE I CLINICAL STUDY OF LL-D49194-ALPHA-1 WITH RETROSPECTIVE PHARMACOKINETIC INVESTIGATIONS IN MICE AND HUMANS.. 31(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | DOSE GIVEN 5 X AT 3 WEEK INTERVALS. PHASE 1 STUDY OF ANTITUMOR ACTIVITY STOPPED DUE TO CARDIOTOXICITY. |
| Dose amount | 0.25 MG |
| Number | 4 |
| Percent yield | 33% |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M BODY SURFACE |
| Dose expression | DOSE |
| Expression result | TWD |